img

Global and United States Targeted Radionuclide Drug Market Report & Forecast 2024-2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global and United States Targeted Radionuclide Drug Market Report & Forecast 2024-2034

Market Analysis and InsightsGlobal and United States Targeted Radionuclide Drug Market
This report focuses on global and United States Targeted Radionuclide Drug market, also covers the segmentation data of other regions in regional level and county level.
The global Targeted Radionuclide Drug revenue was US$ million in 2022 and is forecast to a readjusted size of US$ million by 2033 with a CAGR of % during the review period (2023-2033).
In United States the Targeted Radionuclide Drug revenue is expected to grow from US$ million in 2022 to US$ million by 2033, at a CAGR of % during the forecast period 2023-2033.
The global key players of Targeted Radionuclide Drug include POINT Biopharma, Telix, ITM AG, Bayer AG, Novartis, Lantheus, Curium Pharma, Fusion Pharmaceuticals and RadioMedix, Inc., etc. The global five biggest players hold a share of % in 2022.
Global Targeted Radionuclide Drug Scope and Market Size
Targeted Radionuclide Drug market is segmented in regional and country level, by players, by Type and by Application. Companies, stakeholders, and other participants in the global Targeted Radionuclide Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2018-2033.
For United States market, this report focuses on the Targeted Radionuclide Drug market size by players, by Type and by Application, for the period 2018-2033. The key players include the global and local players, which play important roles in United States.



By Company


POINT Biopharma
Telix
ITM AG
Bayer AG
Novartis
Lantheus
Curium Pharma
Fusion Pharmaceuticals
RadioMedix, Inc.
Convergent Therapeutics
IONETIX
Clarity Pharmaceuticals
RayzeBio, Inc
AmbioPharm
Bracco Imaging
Navidea
China Isotope & Radiation Corporation
Yantai Dongcheng
Grand Pharma
Hengrui Medicine
Yunnan Baiyao Group
SmartNuclide Biopharma
Sinotau
Hexin Pharmaceutical
Segment by Type
Medicine
Inhibitor

Segment by Application


Tumors
Thyroid
Others
By Region
Americas
United States
Canada
Mexico
Brazil
China
APAC (excluding China)
Japan
South Korea
China Taiwan
ASEAN
India
EMEA
Europe
Middle East
Africa

Chapter Introduction


Chapter 1Introduces Targeted Radionuclide Drug definition, global market size, United States market size, United States percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3Provides the analysis of various market segments by application, covering the revenue and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4Detailed analysis of Targeted Radionuclide Drug companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger and acquisition information, etc.
Chapter 5Revenue of Targeted Radionuclide Drug in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 6Americas by type, by application and by country revenue for each segment.
Chapter 7EMEA by type, by application and by region, revenue for each segment.
Chapter 8China by type, by application revenue for each segment.
Chapter 9APAC (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Targeted Radionuclide Drug revenue, gross margin and recent development, etc.
Chapter 11Analyst's Viewpoints/Conclusions

Table of Content

1 Study Coverage
1.1 Targeted Radionuclide Drug Product Introduction
1.2 Global Targeted Radionuclide Drug Outlook 2018 VS 2022 VS 2033
1.2.1 Global Targeted Radionuclide Drug Market Size for the Year 2018-2033
1.2.2 United States Targeted Radionuclide Drug Market Size for the Year 2018-2033
1.3 Targeted Radionuclide Drug Market Size, United States VS Global, 2018 VS 2022 VS 2033
1.3.1 The Market Share of United States Targeted Radionuclide Drug in Global, 2018 VS 2022 VS 2033
1.3.2 The Growth Rate of Targeted Radionuclide Drug Market Size, United States VS Global, 2018 VS 2022 VS 2033
1.4 Targeted Radionuclide Drug Market Dynamics
1.4.1 Targeted Radionuclide Drug Industry Trends
1.4.2 Targeted Radionuclide Drug Market Drivers
1.4.3 Targeted Radionuclide Drug Market Challenges
1.4.4 Targeted Radionuclide Drug Market Restraints
1.5 Assumptions and Limitations
1.6 Study Objectives
1.7 Years Considered
2 Targeted Radionuclide Drug by Type
2.1 Targeted Radionuclide Drug Market Segment by Type
2.1.1 Medicine
2.1.2 Inhibitor
2.2 Global Targeted Radionuclide Drug Market Size by Type (2018, 2022 & 2033)
2.3 Global Targeted Radionuclide Drug Market Size by Type (2018-2033)
2.4 United States Targeted Radionuclide Drug Market Size by Type (2018, 2022 & 2033)
2.5 United States Targeted Radionuclide Drug Market Size by Type (2018-2033)
3 Targeted Radionuclide Drug by Application
3.1 Targeted Radionuclide Drug Market Segment by Application
3.1.1 Tumors
3.1.2 Thyroid
3.1.3 Others
3.2 Global Targeted Radionuclide Drug Market Size by Application (2018, 2022 & 2033)
3.3 Global Targeted Radionuclide Drug Market Size by Application (2018-2033)
3.4 United States Targeted Radionuclide Drug Market Size by Application (2018, 2022 & 2033)
3.5 United States Targeted Radionuclide Drug Market Size by Application (2018-2033)
4 Global Targeted Radionuclide Drug Competitor Landscape by Company
4.1 Global Targeted Radionuclide Drug Market Size by Company
4.1.1 Global Key Companies of Targeted Radionuclide Drug, Ranked by Revenue (2022)
4.1.2 Global Targeted Radionuclide Drug Revenue by Player (2018-2023)
4.2 Global Targeted Radionuclide Drug Concentration Ratio (CR)
4.2.1 Targeted Radionuclide Drug Market Concentration Ratio (CR) (2018-2023)
4.2.2 Global Top 5 and Top 10 Largest Companies of Targeted Radionuclide Drug in 2022
4.2.3 Global Targeted Radionuclide Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Key Players of Targeted Radionuclide Drug Head office and Area Served
4.4 Global Key Players of Targeted Radionuclide Drug, Product and Application
4.5 Global Key Players of Targeted Radionuclide Drug, Date of Enter into This Industry
4.6 Companies Mergers & Acquisitions, Expansion Plans
4.7 United States Targeted Radionuclide Drug Market Size by Company
4.7.1 Key Players of Targeted Radionuclide Drug in United States, Ranked by Revenue (2022)
4.7.2 United States Targeted Radionuclide Drug Revenue by Players (2021, 2022 & 2023)
5 Global Targeted Radionuclide Drug Market Size by Region
5.1 Global Targeted Radionuclide Drug Market Size by Region: 2018 VS 2022 VS 2033
5.2 Global Targeted Radionuclide Drug Market Size by Region (2018-2033)
5.2.1 Global Targeted Radionuclide Drug Market Size by Region: 2018-2023
5.2.2 Global Targeted Radionuclide Drug Market Size by Region (2024-2033)
6 Americas
6.1 Americas Targeted Radionuclide Drug Market Size YoY Growth 2018-2033
6.2 Americas Targeted Radionuclide Drug Market Size by Type
6.2.1 Americas Targeted Radionuclide Drug Market Size by Type (2018-2023)
6.2.2 Americas Targeted Radionuclide Drug Market Size by Type (2024-2033)
6.2.3 Americas Targeted Radionuclide Drug Market Share by Type (2018-2033)
6.3 Americas Targeted Radionuclide Drug Market Size by Application
6.3.1 Americas Targeted Radionuclide Drug Market Size by Application (2018-2023)
6.3.2 Americas Targeted Radionuclide Drug Market Size by Application (2024-2033)
6.3.3 Americas Targeted Radionuclide Drug Market Share by Application (2018-2033)
6.4 Americas Targeted Radionuclide Drug Market Facts & Figures by Country (2018, 2022 & 2033)
6.4.1 United States
6.4.2 Canada
6.4.3 Mexico
6.4.4 Brazil
7 EMEA
7.1 EMEA Targeted Radionuclide Drug Market Size YoY Growth 2018-2033
7.2 EMEA Targeted Radionuclide Drug Market Size by Type
7.2.1 EMEA Targeted Radionuclide Drug Market Size by Type (2018-2023)
7.2.2 EMEA Targeted Radionuclide Drug Market Size by Type (2024-2033)
7.2.3 EMEA Targeted Radionuclide Drug Market Share by Type (2018-2033)
7.3 EMEA Targeted Radionuclide Drug Market Size by Application
7.3.1 EMEA Targeted Radionuclide Drug Market Size by Application (2018-2023)
7.3.2 EMEA Targeted Radionuclide Drug Market Size by Application (2024-2033)
7.3.3 EMEA Targeted Radionuclide Drug Market Share by Application (2018-2033)
7.4 EMEA Targeted Radionuclide Drug Market Facts & Figures by Country (2018, 2022 & 2033)
7.4.1 Europe
7.4.2 Middle East
7.4.3 Africa
8 China
8.1 China Targeted Radionuclide Drug Market Size YoY Growth 2018-2033
8.2 China Targeted Radionuclide Drug Market Size by Type
8.2.1 China Targeted Radionuclide Drug Market Size by Type (2018-2023)
8.2.2 China Targeted Radionuclide Drug Market Size by Type (2024-2033)
8.2.3 China Targeted Radionuclide Drug Market Share by Type (2018-2033)
8.3 China Targeted Radionuclide Drug Market Size by Application
8.3.1 China Targeted Radionuclide Drug Market Size by Application (2018-2023)
8.3.2 China Targeted Radionuclide Drug Market Size by Application (2024-2033)
8.3.3 China Targeted Radionuclide Drug Market Share by Application (2018-2033)
9 APAC (excluding China)
9.1 APAC Targeted Radionuclide Drug Market Size YoY Growth 2018-2033
9.2 APAC Targeted Radionuclide Drug Market Size by Type
9.2.1 APAC Targeted Radionuclide Drug Market Size by Type (2018-2023)
9.2.2 APAC Targeted Radionuclide Drug Market Size by Type (2024-2033)
9.2.3 APAC Targeted Radionuclide Drug Market Share by Type (2018-2033)
9.3 APAC Targeted Radionuclide Drug Market Size by Application
9.3.1 APAC Targeted Radionuclide Drug Market Size by Application (2018-2023)
9.3.2 APAC Targeted Radionuclide Drug Market Size by Application (2024-2033)
9.3.3 APAC Targeted Radionuclide Drug Market Share by Application (2018-2033)
9.4 APAC Targeted Radionuclide Drug Market Facts & Figures by Country (2018, 2022 & 2033)
9.4.1 Japan
9.4.2 South Korea
9.4.3 China Taiwan
9.4.4 Southeast Asia
9.4.5 India
10 Key Players Profiles
10.1 POINT Biopharma
10.1.1 POINT Biopharma Company Details
10.1.2 POINT Biopharma Business Overview
10.1.3 POINT Biopharma Targeted Radionuclide Drug Introduction
10.1.4 POINT Biopharma Revenue in Targeted Radionuclide Drug Business (2018-2023)
10.1.5 POINT Biopharma Recent Development
10.2 Telix
10.2.1 Telix Company Details
10.2.2 Telix Business Overview
10.2.3 Telix Targeted Radionuclide Drug Introduction
10.2.4 Telix Revenue in Targeted Radionuclide Drug Business (2018-2023)
10.2.5 Telix Recent Development
10.3 ITM AG
10.3.1 ITM AG Company Details
10.3.2 ITM AG Business Overview
10.3.3 ITM AG Targeted Radionuclide Drug Introduction
10.3.4 ITM AG Revenue in Targeted Radionuclide Drug Business (2018-2023)
10.3.5 ITM AG Recent Development
10.4 Bayer AG
10.4.1 Bayer AG Company Details
10.4.2 Bayer AG Business Overview
10.4.3 Bayer AG Targeted Radionuclide Drug Introduction
10.4.4 Bayer AG Revenue in Targeted Radionuclide Drug Business (2018-2023)
10.4.5 Bayer AG Recent Development
10.5 Novartis
10.5.1 Novartis Company Details
10.5.2 Novartis Business Overview
10.5.3 Novartis Targeted Radionuclide Drug Introduction
10.5.4 Novartis Revenue in Targeted Radionuclide Drug Business (2018-2023)
10.5.5 Novartis Recent Development
10.6 Lantheus
10.6.1 Lantheus Company Details
10.6.2 Lantheus Business Overview
10.6.3 Lantheus Targeted Radionuclide Drug Introduction
10.6.4 Lantheus Revenue in Targeted Radionuclide Drug Business (2018-2023)
10.6.5 Lantheus Recent Development
10.7 Curium Pharma
10.7.1 Curium Pharma Company Details
10.7.2 Curium Pharma Business Overview
10.7.3 Curium Pharma Targeted Radionuclide Drug Introduction
10.7.4 Curium Pharma Revenue in Targeted Radionuclide Drug Business (2018-2023)
10.7.5 Curium Pharma Recent Development
10.8 Fusion Pharmaceuticals
10.8.1 Fusion Pharmaceuticals Company Details
10.8.2 Fusion Pharmaceuticals Business Overview
10.8.3 Fusion Pharmaceuticals Targeted Radionuclide Drug Introduction
10.8.4 Fusion Pharmaceuticals Revenue in Targeted Radionuclide Drug Business (2018-2023)
10.8.5 Fusion Pharmaceuticals Recent Development
10.9 RadioMedix, Inc.
10.9.1 RadioMedix, Inc. Company Details
10.9.2 RadioMedix, Inc. Business Overview
10.9.3 RadioMedix, Inc. Targeted Radionuclide Drug Introduction
10.9.4 RadioMedix, Inc. Revenue in Targeted Radionuclide Drug Business (2018-2023)
10.9.5 RadioMedix, Inc. Recent Development
10.10 Convergent Therapeutics
10.10.1 Convergent Therapeutics Company Details
10.10.2 Convergent Therapeutics Business Overview
10.10.3 Convergent Therapeutics Targeted Radionuclide Drug Introduction
10.10.4 Convergent Therapeutics Revenue in Targeted Radionuclide Drug Business (2018-2023)
10.10.5 Convergent Therapeutics Recent Development
10.11 IONETIX
10.11.1 IONETIX Company Details
10.11.2 IONETIX Business Overview
10.11.3 IONETIX Targeted Radionuclide Drug Introduction
10.11.4 IONETIX Revenue in Targeted Radionuclide Drug Business (2018-2023)
10.11.5 IONETIX Recent Development
10.12 Clarity Pharmaceuticals
10.12.1 Clarity Pharmaceuticals Company Details
10.12.2 Clarity Pharmaceuticals Business Overview
10.12.3 Clarity Pharmaceuticals Targeted Radionuclide Drug Introduction
10.12.4 Clarity Pharmaceuticals Revenue in Targeted Radionuclide Drug Business (2018-2023)
10.12.5 Clarity Pharmaceuticals Recent Development
10.13 RayzeBio, Inc
10.13.1 RayzeBio, Inc Company Details
10.13.2 RayzeBio, Inc Business Overview
10.13.3 RayzeBio, Inc Targeted Radionuclide Drug Introduction
10.13.4 RayzeBio, Inc Revenue in Targeted Radionuclide Drug Business (2018-2023)
10.13.5 RayzeBio, Inc Recent Development
10.14 AmbioPharm
10.14.1 AmbioPharm Company Details
10.14.2 AmbioPharm Business Overview
10.14.3 AmbioPharm Targeted Radionuclide Drug Introduction
10.14.4 AmbioPharm Revenue in Targeted Radionuclide Drug Business (2018-2023)
10.14.5 AmbioPharm Recent Development
10.15 Bracco Imaging
10.15.1 Bracco Imaging Company Details
10.15.2 Bracco Imaging Business Overview
10.15.3 Bracco Imaging Targeted Radionuclide Drug Introduction
10.15.4 Bracco Imaging Revenue in Targeted Radionuclide Drug Business (2018-2023)
10.15.5 Bracco Imaging Recent Development
10.16 Navidea
10.16.1 Navidea Company Details
10.16.2 Navidea Business Overview
10.16.3 Navidea Targeted Radionuclide Drug Introduction
10.16.4 Navidea Revenue in Targeted Radionuclide Drug Business (2018-2023)
10.16.5 Navidea Recent Development
10.17 China Isotope & Radiation Corporation
10.17.1 China Isotope & Radiation Corporation Company Details
10.17.2 China Isotope & Radiation Corporation Business Overview
10.17.3 China Isotope & Radiation Corporation Targeted Radionuclide Drug Introduction
10.17.4 China Isotope & Radiation Corporation Revenue in Targeted Radionuclide Drug Business (2018-2023)
10.17.5 China Isotope & Radiation Corporation Recent Development
10.18 Yantai Dongcheng
10.18.1 Yantai Dongcheng Company Details
10.18.2 Yantai Dongcheng Business Overview
10.18.3 Yantai Dongcheng Targeted Radionuclide Drug Introduction
10.18.4 Yantai Dongcheng Revenue in Targeted Radionuclide Drug Business (2018-2023)
10.18.5 Yantai Dongcheng Recent Development
10.19 Grand Pharma
10.19.1 Grand Pharma Company Details
10.19.2 Grand Pharma Business Overview
10.19.3 Grand Pharma Targeted Radionuclide Drug Introduction
10.19.4 Grand Pharma Revenue in Targeted Radionuclide Drug Business (2018-2023)
10.19.5 Grand Pharma Recent Development
10.20 Hengrui Medicine
10.20.1 Hengrui Medicine Company Details
10.20.2 Hengrui Medicine Business Overview
10.20.3 Hengrui Medicine Targeted Radionuclide Drug Introduction
10.20.4 Hengrui Medicine Revenue in Targeted Radionuclide Drug Business (2018-2023)
10.20.5 Hengrui Medicine Recent Development
10.21 Yunnan Baiyao Group
10.21.1 Yunnan Baiyao Group Company Details
10.21.2 Yunnan Baiyao Group Business Overview
10.21.3 Yunnan Baiyao Group Targeted Radionuclide Drug Introduction
10.21.4 Yunnan Baiyao Group Revenue in Targeted Radionuclide Drug Business (2018-2023)
10.21.5 Yunnan Baiyao Group Recent Development
10.22 SmartNuclide Biopharma
10.22.1 SmartNuclide Biopharma Company Details
10.22.2 SmartNuclide Biopharma Business Overview
10.22.3 SmartNuclide Biopharma Targeted Radionuclide Drug Introduction
10.22.4 SmartNuclide Biopharma Revenue in Targeted Radionuclide Drug Business (2018-2023)
10.22.5 SmartNuclide Biopharma Recent Development
10.23 Sinotau
10.23.1 Sinotau Company Details
10.23.2 Sinotau Business Overview
10.23.3 Sinotau Targeted Radionuclide Drug Introduction
10.23.4 Sinotau Revenue in Targeted Radionuclide Drug Business (2018-2023)
10.23.5 Sinotau Recent Development
10.24 Hexin Pharmaceutical
10.24.1 Hexin Pharmaceutical Company Details
10.24.2 Hexin Pharmaceutical Business Overview
10.24.3 Hexin Pharmaceutical Targeted Radionuclide Drug Introduction
10.24.4 Hexin Pharmaceutical Revenue in Targeted Radionuclide Drug Business (2018-2023)
10.24.5 Hexin Pharmaceutical Recent Development
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.2 Data Source
12.2 Disclaimer
12.3 Author Details

List of Figure

List of Tables
Table 1. Targeted Radionuclide Drug Market Size United States VS Global, CAGR (2018 VS 2022 VS 2033)
Table 2. Targeted Radionuclide Drug Market Trends
Table 3. Targeted Radionuclide Drug Market Drivers
Table 4. Targeted Radionuclide Drug Market Challenges
Table 5. Targeted Radionuclide Drug Market Restraints
Table 6. Global Targeted Radionuclide Drug Market Size by Type: 2018 VS 2022 VS 2033 (US$ Million)
Table 7. United States Targeted Radionuclide Drug Market Size by Type: 2018 VS 2022 VS 2033 (US$ Million)
Table 8. Global Targeted Radionuclide Drug Market Size by Application: 2018 VS 2022 VS 2033 (US$ Million)
Table 9. United States Targeted Radionuclide Drug Market Size by Application: 2018 VS 2022 VS 2033 (US$ Million)
Table 10. Global Key Companies of Targeted Radionuclide Drug, Ranked by Revenue (2022) & (US$ Million)
Table 11. Global Targeted Radionuclide Drug Revenue by Player, (US$ Million), 2018-2023
Table 12. Global Targeted Radionuclide Drug Revenue Share by Player, 2018-2023
Table 13. Global Targeted Radionuclide Drug Companies Market Concentration Ratio (CR5 and HHI)
Table 14. Global Targeted Radionuclide Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Targeted Radionuclide Drug as of 2022)
Table 15. Global Key Players of Targeted Radionuclide Drug, Headquarters and Area Served
Table 16. Global Key Players of Targeted Radionuclide Drug, Product and Application
Table 17. Global Key Players of Targeted Radionuclide Drug, Date of Enter into This Industry
Table 18. Companies Mergers & Acquisitions, Expansion Plans
Table 19. Key Players of Targeted Radionuclide Drug in United States, Ranked by Revenue (2022) & (US$ Million)
Table 20. United States Targeted Radionuclide Drug Revenue by Players, (US$ Million), 2021, 2022 & 2023
Table 21. United States Targeted Radionuclide Drug Revenue Share by Players, 2021, 2022 & 2023
Table 22. Global Targeted Radionuclide Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 23. Global Targeted Radionuclide Drug Market Size by Region (2018-2023) & (US$ Million)
Table 24. Global Targeted Radionuclide Drug Market Size Forecast by Region (2024-2033) & (US$ Million)
Table 25. Americas Targeted Radionuclide Drug Market Size by Type (2018-2023) & (US$ Million)
Table 26. Americas Targeted Radionuclide Drug Market Size by Type (2024-2033) & (US$ Million)
Table 27. Americas Targeted Radionuclide Drug Market Size by Application (2018-2023) & (US$ Million)
Table 28. Americas Targeted Radionuclide Drug Market Size by Application (2024-2033) & (US$ Million)
Table 29. Americas Targeted Radionuclide Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 30. Americas Targeted Radionuclide Drug Market Size by Country (2018-2023) & (US$ Million)
Table 31. Americas Targeted Radionuclide Drug Market Size by Country (2024-2033) & (US$ Million)
Table 32. EMEA Targeted Radionuclide Drug Market Size by Type (2018-2023) & (US$ Million)
Table 33. EMEA Targeted Radionuclide Drug Market Size by Type (2024-2033) & (US$ Million)
Table 34. EMEA Targeted Radionuclide Drug Market Size by Application (2018-2023) & (US$ Million)
Table 35. EMEA Targeted Radionuclide Drug Market Size by Application (2024-2033) & (US$ Million)
Table 36. EMEA Targeted Radionuclide Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 37. EMEA Targeted Radionuclide Drug Market Size by Country (2018-2023) & (US$ Million)
Table 38. EMEA Targeted Radionuclide Drug Market Size by Country (2024-2033) & (US$ Million)
Table 39. China Targeted Radionuclide Drug Market Size by Type (2018-2023) & (US$ Million)
Table 40. China Targeted Radionuclide Drug Market Size by Type (2024-2033) & (US$ Million)
Table 41. China Targeted Radionuclide Drug Market Size by Application (2018-2023) & (US$ Million)
Table 42. China Targeted Radionuclide Drug Market Size by Application (2024-2033) & (US$ Million)
Table 43. China Targeted Radionuclide Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. APAC Targeted Radionuclide Drug Market Size by Type (2018-2023) & (US$ Million)
Table 45. APAC Targeted Radionuclide Drug Market Size by Type (2024-2033) & (US$ Million)
Table 46. APAC Targeted Radionuclide Drug Market Size by Application (2018-2023) & (US$ Million)
Table 47. APAC Targeted Radionuclide Drug Market Size by Application (2024-2033) & (US$ Million)
Table 48. APAC Targeted Radionuclide Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 49. APAC Targeted Radionuclide Drug Market Size by Region (2018-2023) & (US$ Million)
Table 50. APAC Targeted Radionuclide Drug Market Size by Region (2024-2033) & (US$ Million)
Table 51. POINT Biopharma Company Details
Table 52. POINT Biopharma Business Overview
Table 53. POINT Biopharma Targeted Radionuclide Drug Product
Table 54. POINT Biopharma Revenue in Targeted Radionuclide Drug Business (2018-2023) & (US$ Million)
Table 55. POINT Biopharma Recent Development
Table 56. Telix Company Details
Table 57. Telix Business Overview
Table 58. Telix Targeted Radionuclide Drug Product
Table 59. Telix Revenue in Targeted Radionuclide Drug Business (2018-2023) & (US$ Million)
Table 60. Telix Recent Development
Table 61. ITM AG Company Details
Table 62. ITM AG Business Overview
Table 63. ITM AG Targeted Radionuclide Drug Product
Table 64. ITM AG Revenue in Targeted Radionuclide Drug Business (2018-2023) & (US$ Million)
Table 65. ITM AG Recent Development
Table 66. Bayer AG Company Details
Table 67. Bayer AG Business Overview
Table 68. Bayer AG Targeted Radionuclide Drug Product
Table 69. Bayer AG Revenue in Targeted Radionuclide Drug Business (2018-2023) & (US$ Million)
Table 70. Bayer AG Recent Development
Table 71. Novartis Company Details
Table 72. Novartis Business Overview
Table 73. Novartis Targeted Radionuclide Drug Product
Table 74. Novartis Revenue in Targeted Radionuclide Drug Business (2018-2023) & (US$ Million)
Table 75. Novartis Recent Development
Table 76. Lantheus Company Details
Table 77. Lantheus Business Overview
Table 78. Lantheus Targeted Radionuclide Drug Product
Table 79. Lantheus Revenue in Targeted Radionuclide Drug Business (2018-2023) & (US$ Million)
Table 80. Lantheus Recent Development
Table 81. Curium Pharma Company Details
Table 82. Curium Pharma Business Overview
Table 83. Curium Pharma Targeted Radionuclide Drug Product
Table 84. Curium Pharma Revenue in Targeted Radionuclide Drug Business (2018-2023) & (US$ Million)
Table 85. Curium Pharma Recent Development
Table 86. Fusion Pharmaceuticals Company Details
Table 87. Fusion Pharmaceuticals Business Overview
Table 88. Fusion Pharmaceuticals Targeted Radionuclide Drug Product
Table 89. Fusion Pharmaceuticals Revenue in Targeted Radionuclide Drug Business (2018-2023) & (US$ Million)
Table 90. Fusion Pharmaceuticals Recent Development
Table 91. RadioMedix, Inc. Company Details
Table 92. RadioMedix, Inc. Business Overview
Table 93. RadioMedix, Inc. Targeted Radionuclide Drug Product
Table 94. RadioMedix, Inc. Revenue in Targeted Radionuclide Drug Business (2018-2023) & (US$ Million)
Table 95. RadioMedix, Inc. Recent Development
Table 96. Convergent Therapeutics Company Details
Table 97. Convergent Therapeutics Business Overview
Table 98. Convergent Therapeutics Targeted Radionuclide Drug Product
Table 99. Convergent Therapeutics Revenue in Targeted Radionuclide Drug Business (2018-2023) & (US$ Million)
Table 100. Convergent Therapeutics Recent Development
Table 101. IONETIX Company Details
Table 102. IONETIX Business Overview
Table 103. IONETIX Targeted Radionuclide Drug Product
Table 104. IONETIX Revenue in Targeted Radionuclide Drug Business (2018-2023) & (US$ Million)
Table 105. IONETIX Recent Development
Table 106. Clarity Pharmaceuticals Company Details
Table 107. Clarity Pharmaceuticals Business Overview
Table 108. Clarity Pharmaceuticals Targeted Radionuclide Drug Product
Table 109. Clarity Pharmaceuticals Revenue in Targeted Radionuclide Drug Business (2018-2023) & (US$ Million)
Table 110. Clarity Pharmaceuticals Recent Development
Table 111. RayzeBio, Inc Company Details
Table 112. RayzeBio, Inc Business Overview
Table 113. RayzeBio, Inc Targeted Radionuclide Drug Product
Table 114. RayzeBio, Inc Revenue in Targeted Radionuclide Drug Business (2018-2023) & (US$ Million)
Table 115. RayzeBio, Inc Recent Development
Table 116. AmbioPharm Company Details
Table 117. AmbioPharm Business Overview
Table 118. AmbioPharm Targeted Radionuclide Drug Product
Table 119. AmbioPharm Revenue in Targeted Radionuclide Drug Business (2018-2023) & (US$ Million)
Table 120. AmbioPharm Recent Development
Table 121. Bracco Imaging Company Details
Table 122. Bracco Imaging Business Overview
Table 123. Bracco Imaging Targeted Radionuclide Drug Product
Table 124. Bracco Imaging Revenue in Targeted Radionuclide Drug Business (2018-2023) & (US$ Million)
Table 125. Bracco Imaging Recent Development
Table 126. Navidea Company Details
Table 127. Navidea Business Overview
Table 128. Navidea Targeted Radionuclide Drug Product
Table 129. Navidea Revenue in Targeted Radionuclide Drug Business (2018-2023) & (US$ Million)
Table 130. Navidea Recent Development
Table 131. China Isotope & Radiation Corporation Company Details
Table 132. China Isotope & Radiation Corporation Business Overview
Table 133. China Isotope & Radiation Corporation Targeted Radionuclide Drug Product
Table 134. China Isotope & Radiation Corporation Revenue in Targeted Radionuclide Drug Business (2018-2023) & (US$ Million)
Table 135. China Isotope & Radiation Corporation Recent Development
Table 136. Yantai Dongcheng Company Details
Table 137. Yantai Dongcheng Business Overview
Table 138. Yantai Dongcheng Targeted Radionuclide Drug Product
Table 139. Yantai Dongcheng Revenue in Targeted Radionuclide Drug Business (2018-2023) & (US$ Million)
Table 140. Yantai Dongcheng Recent Development
Table 141. Grand Pharma Company Details
Table 142. Grand Pharma Business Overview
Table 143. Grand Pharma Targeted Radionuclide Drug Product
Table 144. Grand Pharma Revenue in Targeted Radionuclide Drug Business (2018-2023) & (US$ Million)
Table 145. Grand Pharma Recent Development
Table 146. Hengrui Medicine Company Details
Table 147. Hengrui Medicine Business Overview
Table 148. Hengrui Medicine Targeted Radionuclide Drug Product
Table 149. Hengrui Medicine Revenue in Targeted Radionuclide Drug Business (2018-2023) & (US$ Million)
Table 150. Hengrui Medicine Recent Development
Table 151. Yunnan Baiyao Group Company Details
Table 152. Yunnan Baiyao Group Business Overview
Table 153. Yunnan Baiyao Group Targeted Radionuclide Drug Product
Table 154. Yunnan Baiyao Group Revenue in Targeted Radionuclide Drug Business (2018-2023) & (US$ Million)
Table 155. Yunnan Baiyao Group Recent Development
Table 156. SmartNuclide Biopharma Company Details
Table 157. SmartNuclide Biopharma Business Overview
Table 158. SmartNuclide Biopharma Targeted Radionuclide Drug Product
Table 159. SmartNuclide Biopharma Revenue in Targeted Radionuclide Drug Business (2018-2023) & (US$ Million)
Table 160. SmartNuclide Biopharma Recent Development
Table 161. Sinotau Company Details
Table 162. Sinotau Business Overview
Table 163. Sinotau Targeted Radionuclide Drug Product
Table 164. Sinotau Revenue in Targeted Radionuclide Drug Business (2018-2023) & (US$ Million)
Table 165. Sinotau Recent Development
Table 166. Hexin Pharmaceutical Company Details
Table 167. Hexin Pharmaceutical Business Overview
Table 168. Hexin Pharmaceutical Targeted Radionuclide Drug Product
Table 169. Hexin Pharmaceutical Revenue in Targeted Radionuclide Drug Business (2018-2023) & (US$ Million)
Table 170. Hexin Pharmaceutical Recent Development
Table 171. Research Programs/Design for This Report
Table 172. Key Data Information from Secondary Sources
Table 173. Key Data Information from Primary Sources
List of Figures
Figure 1. Targeted Radionuclide Drug Product Picture
Figure 2. Global Targeted Radionuclide Drug Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 3. Global Targeted Radionuclide Drug Market Size 2018-2033 (US$ Million)
Figure 4. United States Targeted Radionuclide Drug Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 5. United States Targeted Radionuclide Drug Market Size 2018-2033 (US$ Million)
Figure 6. United States Targeted Radionuclide Drug Market Share in Global 2018-2033
Figure 7. Targeted Radionuclide Drug Report Years Considered
Figure 8. Product Picture of Medicine
Figure 9. Product Picture of Inhibitor
Figure 10. Global Targeted Radionuclide Drug Market Share by Type in 2022 & 2033
Figure 11. Global Targeted Radionuclide Drug Market Size by Type (2018-2033) & (US$ Million)
Figure 12. Global Targeted Radionuclide Drug Market Share by Type (2018-2033)
Figure 13. United States Targeted Radionuclide Drug Market Share by Type in 2022 & 2033
Figure 14. United States Targeted Radionuclide Drug Market Size by Type (2018-2033) & (US$ Million)
Figure 15. United States Targeted Radionuclide Drug Market Share by Type (2018-2033)
Figure 16. Product Picture of Tumors
Figure 17. Product Picture of Thyroid
Figure 18. Product Picture of Others
Figure 19. Global Targeted Radionuclide Drug Market Share by Application in 2022 & 2033
Figure 20. Global Targeted Radionuclide Drug Market Size by Application (2018-2033) & (US$ Million)
Figure 21. Global Targeted Radionuclide Drug Market Share by Application (2018-2033)
Figure 22. United States Targeted Radionuclide Drug Market Share by Application in 2022 & 2033
Figure 23. United States Targeted Radionuclide Drug Market Size by Application (2018-2033) & (US$ Million)
Figure 24. United States Targeted Radionuclide Drug Market Share by Application (2018-2033)
Figure 25. The Top 5 and 10 Largest Companies of Targeted Radionuclide Drug in the World: Market Share by Targeted Radionuclide Drug Revenue in 2022
Figure 26. Global Targeted Radionuclide Drug Market Size Market Share by Region: 2018 VS 2022 VS 2033
Figure 27. Global Targeted Radionuclide Drug Market Share by Region (2018-2033)
Figure 28. Americas Targeted Radionuclide Drug Market Size Growth Rate 2018-2033 (US$ Million)
Figure 29. Americas Targeted Radionuclide Drug Market Share by Type (2018-2033)
Figure 30. Americas Targeted Radionuclide Drug Market Share by Application (2018-2033)
Figure 31. United States Targeted Radionuclide Drug Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 32. Canada Targeted Radionuclide Drug Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 33. Mexico Targeted Radionuclide Drug Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 34. Brazil Targeted Radionuclide Drug Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 35. EMEA Targeted Radionuclide Drug Market Size Growth Rate 2018-2033 (US$ Million)
Figure 36. EMEA Targeted Radionuclide Drug Market Share by Type (2018-2033)
Figure 37. EMEA Targeted Radionuclide Drug Market Share by Application (2018-2033)
Figure 38. Europe Targeted Radionuclide Drug Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 39. Middle East Targeted Radionuclide Drug Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 40. Africa Targeted Radionuclide Drug Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 41. China Targeted Radionuclide Drug Market Size Growth Rate 2018-2033 (US$ Million)
Figure 42. China Targeted Radionuclide Drug Market Share by Type (2018-2033)
Figure 43. China Targeted Radionuclide Drug Market Share by Application (2018-2033)
Figure 44. APAC Targeted Radionuclide Drug Market Size Growth Rate 2018-2033 (US$ Million)
Figure 45. APAC Targeted Radionuclide Drug Market Share by Type (2018-2033)
Figure 46. APAC Targeted Radionuclide Drug Market Share by Application (2018-2033)
Figure 47. Japan Targeted Radionuclide Drug Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 48. South Korea Targeted Radionuclide Drug Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 49. China Taiwan Targeted Radionuclide Drug Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 50. Southeast Asia Targeted Radionuclide Drug Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 51. India Targeted Radionuclide Drug Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 52. POINT Biopharma Revenue Growth Rate in Targeted Radionuclide Drug Business (2018-2023)
Figure 53. Telix Revenue Growth Rate in Targeted Radionuclide Drug Business (2018-2023)
Figure 54. ITM AG Revenue Growth Rate in Targeted Radionuclide Drug Business (2018-2023)
Figure 55. Bayer AG Revenue Growth Rate in Targeted Radionuclide Drug Business (2018-2023)
Figure 56. Novartis Revenue Growth Rate in Targeted Radionuclide Drug Business (2018-2023)
Figure 57. Lantheus Revenue Growth Rate in Targeted Radionuclide Drug Business (2018-2023)
Figure 58. Curium Pharma Revenue Growth Rate in Targeted Radionuclide Drug Business (2018-2023)
Figure 59. Fusion Pharmaceuticals Revenue Growth Rate in Targeted Radionuclide Drug Business (2018-2023)
Figure 60. RadioMedix, Inc. Revenue Growth Rate in Targeted Radionuclide Drug Business (2018-2023)
Figure 61. Convergent Therapeutics Revenue Growth Rate in Targeted Radionuclide Drug Business (2018-2023)
Figure 62. IONETIX Revenue Growth Rate in Targeted Radionuclide Drug Business (2018-2023)
Figure 63. Clarity Pharmaceuticals Revenue Growth Rate in Targeted Radionuclide Drug Business (2018-2023)
Figure 64. RayzeBio, Inc Revenue Growth Rate in Targeted Radionuclide Drug Business (2018-2023)
Figure 65. AmbioPharm Revenue Growth Rate in Targeted Radionuclide Drug Business (2018-2023)
Figure 66. Bracco Imaging Revenue Growth Rate in Targeted Radionuclide Drug Business (2018-2023)
Figure 67. Navidea Revenue Growth Rate in Targeted Radionuclide Drug Business (2018-2023)
Figure 68. China Isotope & Radiation Corporation Revenue Growth Rate in Targeted Radionuclide Drug Business (2018-2023)
Figure 69. Yantai Dongcheng Revenue Growth Rate in Targeted Radionuclide Drug Business (2018-2023)
Figure 70. Grand Pharma Revenue Growth Rate in Targeted Radionuclide Drug Business (2018-2023)
Figure 71. Hengrui Medicine Revenue Growth Rate in Targeted Radionuclide Drug Business (2018-2023)
Figure 72. Yunnan Baiyao Group Revenue Growth Rate in Targeted Radionuclide Drug Business (2018-2023)
Figure 73. SmartNuclide Biopharma Revenue Growth Rate in Targeted Radionuclide Drug Business (2018-2023)
Figure 74. Sinotau Revenue Growth Rate in Targeted Radionuclide Drug Business (2018-2023)
Figure 75. Hexin Pharmaceutical Revenue Growth Rate in Targeted Radionuclide Drug Business (2018-2023)
Figure 76. Bottom-up and Top-down Approaches for This Report
Figure 77. Data Triangulation
Figure 78. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries